Skip to main content

Test Price

2,800 AED

✅ Home Collection Available

FGFR1 Gene Trigonocephaly Type 1 Genetic Test in UAE | 2800 AED | 2026 DHA Guidelines

تحليل تسلسل جين FGFR1 لتشخيص تعظم الدروز المثلثي من النوع الأول في الإمارات | 2,800 درهم | معتمد من هيئة الصحة بدبي

Executive Summary | ملخص تنفيذي

يوفر هذا التحليل الجيني المتطور تسلسل الجين FGFR1 باستخدام تقنية التسلسل من الجيل التالي (NGS) بدقة تشخيصية تصل إلى 99.9%، لتشخيص تعظم الدروز المثلثي من النوع الأول ومتلازمات الدروز الملتحمة المرتبطة به. الفحص معتمد من هيئة الصحة بدبي ووزارة الصحة ووقاية المجتمع، مع خدمة سحب منزلي مهني ونتائج موثوقة خلال 3-4 أسابيع، ودعم استشاري وراثي مجاني بعد النتائج.

Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO‑accredited NGS processing (ISO 9001:2015 Cert: INT/EGQ/2509DA/3139).
Premium Logistics: Paid Hospital‑Grade Home Collection with ISO‑Certified Cold‑Chain transport and VIP Mobile Phlebotomy (8 AM–11 PM).
Clinical Guidance: Telephonic Post‑Test Clinical Guidance with a genetic counsellor for result interpretation.
Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.

Overview

The FGFR1 Gene Trigonocephaly Type 1 Genetic Test is a highly precise diagnostic tool that decodes the entire coding region of the FGFR1 gene to identify pathogenic variants responsible for trigonocephaly and related craniosynostosis syndromes. This test is essential for families seeking a definitive molecular diagnosis, guiding surgical and clinical management.

Feature Our Test (FGFR1 NGS) Alternative (Sanger Sequencing)
Precision >99.9% analytical sensitivity and specificity for single-nucleotide variants and indels ~99% sensitivity, limited to targeted regions; may miss low-level mosaicism
Method Next‑Generation Sequencing (NGS) with capture‑based enrichment and bioinformatic analysis Bidirectional Sanger sequencing of selected exons only
Turnaround 3–4 weeks (complete report with expert interpretation) 4–8 weeks and often requires reflex to NGS for comprehensive results

The test is performed under DHA license 9834453 and follows 2026 DHA guidelines for genetic testing.

Physician Insight & Safety Protocol

Dr. PRABHAKAR REDDY (DHA: 61713011) notes: “Every child’s craniofacial journey is unique; this genetic test uncovers the molecular blueprint behind trigonocephaly, empowering families and surgeons with precision answers. It is crucial to interpret results within the full clinical context, and I strongly advise post‑test counselling to translate findings into a safe, personalized care plan. Never make treatment decisions without your specialist’s guidance.”

Safety & Exclusion Criteria

  • Exclusion: Inability to provide informed consent (for minors, legal guardian must be present). Patients with severe coagulopathy or active infection at the venipuncture site require medical clearance before sample collection.
  • Medication Warning: Do not discontinue any prescribed medication without consulting your doctor. This test does not interfere with routine medications.
  • Emergency Red Flags: After blood draw, seek immediate medical attention if you experience large hematoma, excessive bleeding, fainting, or signs of infection (fever, redness, swelling).For medical emergencies, call 998 or visit the nearest ER.

Pre‑Test Preparation

  • • Provide a detailed clinical history including family pedigree of craniosynostosis.
  • • Attend a mandatory genetic counselling session to document affected relatives and assess inheritance patterns.
  • • Sample types accepted: Whole Blood (EDTA), Extracted DNA, or Dried Blood Spot on FTA Card.

Patient FAQ & Clinical Guidance

What conditions can the FGFR1 gene test detect?

The FGFR1 gene test detects pathogenic variants causing trigonocephaly type 1 and related craniosynostosis syndromes. This includes Pfeiffer syndrome, Muenke syndrome, and isolated metopic craniosynostosis. Identifying a mutation allows precise diagnosis, prognostic counselling, and tailored surgical timing.

ما هي الحالات التي يكشف عنها اختبار جين FGFR1؟

يكشف اختبار الجين FGFR1 عن الطفرات المسببة لتعظم الدروز المثلثي من النوع الأول ومتلازمات الدروز الملتحمة المرتبطة، مثل متلازمة فايفر ومتلازمة ميونكه، مما يتيح تشخيصاً دقيقاً وتخطيطاً جراحياً آمناً.

What is the turnaround time for results?

Your FGFR1 genetic test result turnaround time is 3-4 weeks, including sequencing and clinical annotation. Our laboratory processes samples using NGS with rigorous bioinformatics and expert review to ensure every variant is confidently classified before the final report is issued.

كم تستغرق مدة الحصول على النتائج؟

مدة الحصول على نتائج اختبار FGFR1 الوراثي هي 3-4 أسابيع، تشمل التسلسل الجيني والتعليق السريري من قبل أخصائيين.

Will my health insurance cover this?

UAE insurers frequently cover FGFR1 gene tests for trigonocephaly if medically necessary; we verify benefits. Coverage depends on your policy and the referring physician’s justification; our team handles direct billing verification via WhatsApp and can provide a pre‑approval assistance letter.

هل يغطي التأمين الصحي هذا الاختبار؟

تغطي شركات التأمين في الإمارات غالباً اختبارات جين FGFR1 لتعظم الدروز المثلثي عند الحاجة الطبية؛ نتحقق من المزايا ونساعد في الموافقة المسبقة.

This service complies with Federal Decree-Law No. 41 of 2024 (Art. 87) on healthcare provider obligations, the CDS Law 2026 for minors, and UAE PDPL data privacy regulations. DHA License 9834453. ISO 9001:2015 Certified (Cert: INT/EGQ/2509DA/3139). All genetic counselling follows MOHAP standards.

LOINC: 51969-6 | ICD‑10: Q75.0, Q87.0, Z13.71 | Methodology: Next‑Generation Sequencing (NGS).

دعم ثنائي اللغة متاح

التحقق من التغطية التأمينية

Check Insurance Coverage Instantly

Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.

توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.

✅ DHA Certified ✅ ISO 15189 ✅ HIPAA Compliant

Available in Arabic, English, Hindi & Urdu

🏅

ISMS 27001:2022

📋

ISO Accredited

🔒

HIPAA

All reports reviewed by DHA-Certified physicians